Actuate TherapeuticsACTU
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 25 institutions reported holding Actuate Therapeutics Inc. (ACTU) in their 13F filings, up 6 from Q4 2024. 9 opened new positions and 3 sold out. The largest holders were BIOS Capital Management, LP ($67.0M), Voss Capital, LP ($964K) and Northern Trust Corp. ($365K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Actuate Therapeutics Inc.
- CUSIP
- 005083100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $1.2M |
| Exits | 3 | $168K |
All 13F filers, Q4 2024 → Q1 2025: 306,654 shares bought and 21,198 shares sold, net +285,456 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| BIOS Capital Management, LP | 84.59% | No change | 9,893,651 | $67.0M |
| Voss Capital, LP | 0.07% | Add +157.7% | 142,381 | $964K |
| Northern Trust Corp. | 0.00% | New | 53,852 | $365K |
| Susquehanna International Group, LLP | 0.00% | New | 47,634 | $322K |
| Geode Capital Management, LLC | 0.00% | Add +20.1% | 33,489 | $227K |
| Northwestern University | 0.30% | No change | 27,778 | $188K |
| Sigma Planning Corp | 0.01% | Add +47.3% | 23,675 | $160K |
| Goldman Sachs Group Inc. | 0.00% | Add +98.7% | 22,358 | $151K |
| Royal Bank of Canada | 0.00% | Add +6038.4% | 18,538 | $126K |
| Vanguard Group Inc. | 0.00% | Add +29.9% | 18,574 | $126K |
| Mercer Global Advisors Inc. | 0.00% | No change | 16,344 | $111K |
| Marshall Wace, LLP | 0.00% | New | 16,114 | $109K |
| Chicago Partners Investment Group LLC | 0.00% | New | 10,365 | $96K |
| Citadel Advisors | 0.00% | New | 14,185 | $96K |
| Millennium Management | 0.00% | New | 12,185 | $82K |
| KG Capital Management | 0.03% | No change | 12,000 | $81K |
| Sfmg, LLC | 0.01% | New | 11,000 | $74K |
| Freestone Capital Holdings, LLC | 0.00% | No change | 10,000 | $68K |
| BlackRock, Inc. | 0.00% | Reduce -1.9% | 7,598 | $51K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 3,125 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,555 | $17K |
| UBS Group AG | 0.00% | Add +2.3% | 1,979 | $13K |
| Morgan Stanley | 0.00% | Add +183.8% | 1,538 | $10K |
| Citigroup Inc. | 0.00% | Add +32350.0% | 649 | $4K |
| Bank of America Corp. | 0.00% | Add +4.2% | 25 | $169 |
"% of holder's portfolio" is ACTU's weight in each manager's 13F, not the share of Actuate Therapeutics Inc. the manager owns.